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The mucinoses comprise a group of conditions characterized by the accumula-
tion in the cutis of a material known as "mucin". Mucin has more or less specific
staining properties but its exact chemical nature has never been fully determined.
It is found in large quantities in the so-called myxoedematous conditions of the
skin and in smaller quantities as degenerative changes in certain neoplasms of
the connective tissue. It has also been identified as a normal constituent of skin
in very small amounts in the interstices of connective tissue (1).
The mucinoses may be conveniently classified into two main groups: the
myxoedemas or metabolic mucinoses and the secondary or catabolic mucinoses.
Myxoedemas are designated as metabolic mucinoses, since in these diseases
there seems to be some metabolic disturbance (perhaps endocrine in nature) as
the basis for the deposition of the mucin. In this group, the process appears to
be reversible and involves the deposition of large amounts of mucin either gen-
erally distributed or localized in relatively large areas. The secondary or catabolic
mucinoses include all those in which mucin is deposited as a degenerative product
of connective tissue as in certain types of tumors; namely, sarcomata, fibromata
and lipomata. These changes are not reversible and are not accompanied by any
apparent endocrine dysfunction.
THE METABOLIC MUCINOSES
The name myxoedema (from the Greek meaning mucin plus swelling) was
coined by Ord in 1878 to describe the swelling and excess of mucin found in the
skin of a patient with marked hypothyroidism. Since that time the term has
been inseparably associated with under-activity of the thyroid gland. The
classic characteristics of generalized myxoedema and its speedy response to
thyroid therapy are well known and offer no diagnostic etiological problem.
Suffice to say that it is the most common of the myxoedemas; is four to five
times more common in females and invariably follows complete removal or
destruction of the thyroid tissue either by operation, thyroiditis or atrophy of
the gland.
The localized forms of myxoedema offer more of an etiological challenge, how-
ever, since some of the reported cases are associated with hypothyroidism, some
with thyrotoxicosis and in rare instances with no apparent dysfunction of the
thyroid at all. Because some of the first reported cases responded to thyroid
medication, it was assumed that all were related to hypothyroidism. In 1931,
however, Pillsbury and Stokes (2), in a critical review of all previously reported
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cases of localized myxoedema, divided them into two distinct groups. They
noted that while the cases associated with underactivity of the thyroid had
papular, lichenoid, nodular or tuberose lesions and occurred on any part of the
body, those constantly associated with past or present thyrotoxicosis presented
only plaque-like lesions, limited to the pretibial areas. Only cases in the first
group were responsive to thyroid therapy. This division of the two types of
localized myxoedema was later emphasized by Carol (3) (1932) and by Schuer-
mann (4) (1938). Schuermann considers the first group, the localized myxoedema
with hypothyroidism, as examples of underactivity of the thyroid in which the
mucin in the skin has happened to become aggregated in local deposits instead
of being uniformly distributed. In view of the prompt response of this type of
myxoedema to thyroid, this seems a reasonable hypothesis.
The type associated with past or present thyrotoxicosis is the most common
and was named circumscribed pretibial myxoedema by Trotter & Eden (5)
(1942), and renamed myxoedema circumscriptum thyrotoxicum by E. L. Cohen
(6) (1946) because the lesions are not strictly confined to the pretibial areas.
They are bilateral, irregular, firm, plaque-like swellings of uneven contour,
TABLE 1
Classification of the rnncinoses
I. Metabolic Mucinoses.
(A) Generalized myxoedema (with hypothyroidism)
(B) Localized myxoedema (with hypothyroidism)
(C) Localized myxoedema (without hypothyroidism)
(D) Myxoedema circumscriptum thyrotoxicum (pretibial myxoedema).
II. Catabolic Mucinoses.
Degenerative Neoplasms
(a) Sarcomata
(b) Fibromata
(c) Lipomata
usually beginning on the antero-lateral aspect of the lower half of the legs, but
may extend upwards to the knee and the back of the legs and rarely to the dorsa
of the feet. The color varies from pink to brown and there is a characteristic
"pig-skin" appearance of the surface. Coarse hairs are occasionally seen in the
plaques (Figure 1).
The essential differences between the two main types of localized myxoedema
are outlined in table 2.
Although the above two forms of localized myxoedema constitute the vast
majority of reported cases, a third group was suggested by Trotter and Eden (5)
(1942) to include a case reported by Per and Rossiansky (1928) and one of their
own in which there occurred widespread mucin-containing papules with no signs
of thyroid dysfunction.
Histopathology
The histological changes in all the metabolic myxoedemas are remarkably con-
stant. In a study of the histopathologic features of 13 cases of generalized myxo-
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edema with hypothyroidism Reuter (1) found "pronounced edematous changes
in the corium, and in consequence a spreading apart of the collagen and elastic
fibers associated with mild degenerative changes: A sparse cellular infiltrate
about the vessels in the upper part of the cutis, and in a few cases about the hair
follicles and sweat glands; and the constant presence of a mucinous staining
material in considerable quantities". In the localized types of myxoedema, in-
cluding the pretihial, Pillsbury and Stokes (2) found an essentially similar picture.
These authors and others, however, have stressed the large number of stellate
FIG. 1. PLAQUE-LIKE LESION OF PRE-TIBIAL MYXOEDEMA ASSOCIATED WITH THYROT0xIC0SIS
cells present in the cutis, scattered about in areas in which delicate fibrillae of
newly formed connective tissue could be discerned. The most marked and
constant feature in all cases of primary myxoedema seems to be the presence in
large amounts of mucin in the cutis.
Pat ho genesis
Although localized myxoedema with hypothyroidism has an obvious etiologic
background and responds to thyroid treatment, in pretibial myxoedema causa-
.
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tive mechanisms are obscure. Trotter and Eden (5) (1942) in an analysis of 69
published cases, noted that the pretihial lesions appeared before treatment for
the thyrotoxicosis in about 50% of the cases. Of those occurring after thyroid-
ectomy, many had already developed recurrence of toxic manifestations at the
time the pretibial lesions were first detected. In some others there was evidence
that all signs of thyrotoxicosis had not been abolished by the operation. There
were some cases in this group, however, that showed no signs of present thyro-
toxicosis and some had definitely lowered basal metabolic rates. From this study,
Trotter and Eden conclude that pretibial myxoedema may appear at any stage
in the course of a case of toxic diffuse goiter, although it is seen most commonly
during the phase of active thyrotoxicosis: also that it cannot be the result of
either hypothyroidism or thyrotoxicosis per Se.
TABLE 2
Essential differences between two main types of localized myxoedema
LOCALIZED MYXOEDEMA WITH
H I I MYXOEDEMA
Morphology Papular, lichenoid, nodular Plaque-like swellings
or tuberose
Distribution Any part of body—rarely on Pretibial areas
legs
Relation to thyroid dysfunc- With hypothyroidism With past or present thyro
tion toxicosis
Response to thyroid medica- Good None
tion
Prognosis Good with thyroid medica- Spontaneous remission after
tion several years (reported by
several authors)
According to the older theories of the pathogenesis of pretibial myxoedema, it
is directly or indirectly associated with a form of hypothyroidism. Thus a state
of "local hypothyroidism" is postulated by some; others suppose the lesions to
be the relics of a previous hypothyroidism which has been overtaken by thyro-
toxicosis and still others believe that the lesions represent a state of hypothy-
roidism underlying a dysthyroidism, which is the cause of the toxic symptoms.
Trotter and Eden deny that hypothyroidism plays any part in the process. They
claim that because this condition is found in a proportion of cases with hypo-
thyroidism (after thyroidectomy) and in a proportion of cases with existing
thyrotoxicosis, there must be a common factor present in both these conditions
responsible for the lesions of pretibial myxoedema. This factor they believe to he
overactivity of the pituitary gland, because there is good evidence (Cope (7)
1938) that overactivity of the pituitary is the immediate cause of thyrotoxicosis
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and also some evidence (Marine, Rosen and Stark, 1934 (8)) that destruction of
the thyroid by operation or disease results in compensatory overactivity of the
pituitary.
SECONDARY MUCINOSES
The secondary or catabolic mucinoses comprise a group of conditions in which
excess mucin is probably formed as a degenerative product of connective tissue.
This type of degeneration is known as mucoid or myxomatous degeneration and
is seen most frequently in sarcomata and occasionally in fibromata and lipomata.
The exact source of the mucinous material is unknown. Many workers claim it is
a breakdown product of collagen (McLeod and Muende (9)), (Delafield and
Prudden (10)) and others that it is the direct product of the connective tissue
cells. According to Kreibich (11), mucin is a trophic product of abnormally
placed fibroblasts, since it is always found around young and immature fibro-
blasts and it diminishes in quantity in old connective tissue. An answer to the
question of the origin of mucinous degeneration must depend on further elucida-
tion of the chemical nature of mucin. This subject has recently been greatly en-
lightened by biochemical investigations of the mucopolysaccharides.
THE NATURE OF MUCIN
Knowledge concerning the nature of mucin has for a long time been confined
to its reaction with histological stains. From a histo-chemical standpoint, mucin
has the following characteristics (Carleton (12), 1925): "Great affinity for basic
dyes in general, due to the acid reaction of mucin: metachromatic staining with
certain basic aniline dyes; solubility in weak alkalis and precipitation by acetic
acid. Mucin is coagulated into threads by alcohol and corrosive mercuric chloride,
and in this form it can be stained by a number of staining reagents such as poly-
chrom methylene blue, thionine or muci-carmine".
It is now firmly established that what we speak of as mucin is actually a com-
bination of protein and other substances. Mucin or mucoid is a non-descript
term that seems to have been applied to any viscid material in the body having
the characteristics enumerated above. In 1934, Meyer and Palmer (13) isolated
hyaluronic acid, a sulfur-free polysaccharide, containing glucosamine, glucuronic
acid and an acetyl group, from mucinous body tissues, such as umbilical cord,
vitreous humor and synovial fluid. Chain and Duthie (14) (1940) isolated a sub-
stance with properties similar to hyaluronic acid from rabbit skin and in 1941,
Meyer and Chaffee (15) obtained hyaluronic acid and chondroitin-sulphuric acid
from pig-skin. Watson and Pearce (16) (1946) found hyaluronic acid and other
mucopolysaccharides in specimens of human skin from freshly amputated legs
and radical mastectomies. They also presented evidence to show that the content
of mucopolysaccharides, including hyaluronic acid was greater than normal in
the affected skin of two patients with pretibial myxoedema. Many years earlier
it had been discovered (Schneideberg (17), (1891)) that the hydrolysates of the
viscid material extracted from cartilage contained amino sugar, uronic, acetic
and sulphuric acids. This polysaccharide was named chondroitin-sulphuric acid.
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Levene (18) (1925) showed that the molecular components of chondroitin
sulphuric acid were galactoseamine, glucuronic acid, acetyl and sulphuric acids.
He isolated this material from cartilage, tendon, aorta and sclcra.
Hyaluronidase was first described by Meyer, Dubos and Smyth (19) in 1936.
These authors found that an enzyme present in pneumococcus had the property
of hydrolysing the polysaccharide found in vitreous humor and umbilical cord.
This material was found to be similar in properties to the "spreading factor"
dcscribed by Duran-Reynals (20) in 1928. The "spreading factor" was extracted
from rodent testes and had been shown to increase the infectivity of vaccine
virus upon intradermal injection in rabbits. In recent years this substance has
been found in other tissues, although the testes remain the best source. Some
other tissues which contain the enzyme are kidney, skin, epididymis, lung, brain,
cmbryonal and placental tissue and certain malignant tumors. It also occurs in
snake venoms, bee stings, the whole bodies of spiders and offensive insects, leeches
and bacteria.
The characteristic action of hyaluronidase is to first depolymerize and then
hydrolyse the polysaccharide. The reactions characteristic of the intact polymer
disappear, such as the property of forming a turbid sol with protein, and of
forming a clot, and then the viscosity of the solution falls. Products of thc
hydrolysis such as reducing sugars can then be detected.
It was first suggested by Chain and Duthie (14) (1940) that hyaluronic acid,
which they isolated in small amounts from normal skin, might be a constituent
of the substance causing the swelling in pretihial myxoedema. Trotter and Eden
(5) in 1942 also refer to this possibility and state "If it could be shown that injec-
tion of hyaluronidase caused these swellings to disappear important information
as to their chemical nature would have been obtained, as well as an effective
method of treatment".
INVE5TIGATIVE WOEK
I. Methods
In order to pursue the investigation of the nature of the mucinous swelling in pretibial
myxoedema along the lines suggested by Trotter and Eden, it was necessary to find a stain-
ing technic that would distinctively stain the acid polysaccharidcs in connective tissue.
The mucin stains generally used are non-specific in nature and the particular element of
the complex structure that makes up "mucin" which they stain is not known. Furthermore,
aqueous fixatives, such as formaldehyde, which act chiefly as protein fixatives, do not fix
hyaluronic acid which dissolves out into the solution and into the subsequent washing
water. Toluidine blue is satisfactory for the sulphated polysaccharides, such as chondroitin
sulphate, which stain metachromatically, but is of less value for hyaluronic acid and other
acid polysaccharides that do not contain sulphate and do not stain metachromatically. A
technic that stains all the acid polysaccharides, including hyaluronic acid and chondroitin
sulphuric acid, has recently been described by Hale (25). In principle, the method depends
upon the treatment of the tissue with a suitable fixative; after dehydration and preparation
of a paraffin block, sections are cut, mounted and then treated with an acid solution of ferric
hydroxide. The iron combines with acid polysaccharides but not with neutral polysaccha-
rides or proteins. The combined iron is then demonstrated as Prussian blue by treatment
with hydrochloric acid and potassium ferrocyanide. If the sections are counterstained with
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a red dye, such as fuchsin, the acid polysaccharides are stained blue against a red back-
grouad of other tissue structures.
Although this stain does not differentiate between hyaluronic acid and the other poly-
saccharides, it was reasoned that a rough estimate of the amount of hyaluronic acid in the
mucinous swelling of pretibial myxoedema could he obtained by staining (with the Hale
method) biopsies taken before and after the injection of hyalurnnidase. Thus, if there is an
appreciable amount of hyaluronic acid present, it should be hydrolysed by the hyaluroni-
dase and combination of the polysaccharide with the iron should be prevented. This would
be indicated by a lesser amount of blue staining material in the "after" biopsy. This reason-
ing is predicated on the assumption that hyalurenic acid is the specific substrate for hy-
aluronidase and no other substance is broken down by its action. This view is now held by
most investigators, including Duran-Reynals (20), based on the failure of hyaluronidase to
break down mucin from various portions of the digestive tract or from the cervix uteri or
such materials as chondroitin sulphate.
Studies were carried out on two patients with pretihial myxoedema and in addition the
therapeutic effects of local injections of hyaluronidase were evaluated.
II. Experimental studies
150 TRTJ (turbidity reducing units) of hyaluronidase (obtained from the
Schering Corporation) dissolved in 1 cc. of physiological saline were injected
intradermafly into a small area of the pretibial plaque and biopsies obtained
before and one hour after injection. rrhe biopsies were stained with the Hale
technic as described above.
III. Results
Sections stained with the Hale technic before injection of hyaluronidase showed
the typical spreading apart of the collagen with infiltration throughout the cutis
of bluish-staining material which, according to Hale, is mucopolysaccharidc.
High power showed that the collagen bundles were intact and stained blue giving
credence to the supposition that mucopolysaccharides compose the cementing
substance or interfibrillar material of the collagen bundles (Figure 2).
High power view, one hour after injection of hyaluronidase, revealed a com-
plete breakdown of the normal architecture of the cutis. Instead of intact collagen
bundles, there were shreds of blue-staining material interspersed in a large
necrotic area which had lost its characteristic staining properties and structure
(Figure 3).
These studies, though incomplete, suggest very strongly that a large part of
the material making up the mucinous swelling of pretibial myxoedema is hyal-
uronic acid. They also point out the highly destructive action of hyaluronidase
on collagen and explain the peculiar spreading properties of the enzyme.
Therapeutic studies
To study the possible therapeutic effects of hyaluronidase, this substance was
injected intradermally in quantities of 150 units dissolved in I cc. of saline into
the lesions of two patients with prctibial myxocdema. The enzyme was injected
into the same areas daily for ten days. The immediate result was a softening of
the tissue to the extent of producing a definite feeling of herniation on palpation
and the disappearance of the nodular elevations on the plaque. The patients,
166 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
FIG. 2. HIGH POWER VIEW OF CUTIS OF PATIENT WITH PEE-TIBIAL MYXOEDEMA (HALE
STAIN). SAME PATIENT AS IN FIG. 1
FIG. 3. HIGH POWER VIEW OF CUTIS OF SAME PATIENT, ONE HOUE AFTER INJECTION OF
150 TUEBIDITY REDUCING UNITS OF HYALTJEONIDASE (HALE STAIN)
several months after treatment, showed definite areas of soft, normal skin within
the patch at the areas of injection with hyaluronidase.
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Further study with this substance as a therapeutic agent is necessary before
it can be recommended for routine therapy.
SUMMARY
1. A classification of the mucinoses is presented which separates these condi-
tions into two large groups: the metabolic mucinoses, which include the various
myxoedematous conditions and are characterised by large deposits of "mucin"
in the skin and appear to be reversible disorders of metabolism under endocrine
influence, and the catabolic mucinoses, which are probably due to mucinous
degeneration of connective tissue, as in sarcomas, fibromas and lipomas.
2. The essential points of difference between the various types of localized
myxoedema are enumerated.
3. Evidence is presented to show that a considerable portion of the material
making up the mucinous swelling in myxoedema circumscriptum thyrotoxicum
or pretibial myxoedema is composed of the mucopolysaccharide, hyaluronic acid.
4. The therapeutic effect of injections of hyaluronidase into the lesions of pre-
tibial myxoedema is evaluated.
REFERENCES
1. REUTEE, M. J.: Histopathology of Skin in Myxoedema. Arch. Dermat. & Syph. 24:
55, 1931.
2. PILLSBURY, D.M. AND J. H. SToKEs: Circumscribed Myxoedema of Skin. Arch. Dermat
& Syph. 24: 255, 1931.
3. CAROL, W. 1. L.: tiber Atypisches Myxodem. Acta Dermato-Venerologica 13: 127, 1932.
4. SCFIUERMANN, H.: tYher Hauterscheinungen mit Beziehung zu Myxodem und Base
dowseher Kraokheit. Arch. f. Dermat. u. Syph. 176: 544, 1938.
5. TROTTER, W. H. ANO K. C. EDEN: Localized Pretibial Myxoedema in Association with
Toxic Goiter. Quart. J. Med. 35: 229, 1942.
6. COHEN, E. L.: Myxoedema Circumscriptum Thyrotoxicum. Brit. J. Dermat. 58: 173,
1946.
7. COPE, C. L.: Anterior Pituitary Lobe in Graves Disease and in Myxoedema. Quart. J.
Med. U. S. 7:151, 1938.
8. MARINE, D. S., H. ROSEN AND 0. STARK: Effect of Iodine and Dessicated Thyroid on
Anterior Pituitary of Goitrous and Thyroidectomized Rabbits. Proc. Soc. Exp. Biol.
& Med. 32: 803, 1934—5.
9. MCLEOD, J. M. H. AND I. MUENDE: Practical Handbook of the Pathology of the Skin.
Paul B. Hoeber, Inc., New York.
10. DELAFIELD, F. AND T. RI. PRUDDEN: Text Book of Pathology, William Wood & Co.,
N.Y.
11. Krtmnicii, C.: Mucin Bei Hauterkrankung. Arch. f. Dermat. u. Syph. 153: 799, 1927.
12. CARLETON, H. V. M.: Histological Technique for Normal Tissues, Morbid Changes and
the Identification of Parasites, N. Y., Oxford Clin. Press, 1925.
13. MEYER, K. AND J. W. PALMER: Polysaccharide of Vitreous Humor. J. Biol. Chem. 107:
629, 1934.
14. CHAIN, E. AND E. S. DUTHIE: Identity of hyaluronidaso and spreading factor. Brit. J.
Exp. Path. 21: 324, 1940.
15. MEYER, K. AND E. CHAFFER: Mucopolysaccharides of skin. J. Biol. Chem. 138: 491,
1941.
16. WATSON, E. M. AND H. H. PEARCE: Biochemistry of Skin; review, with particular re-
ference to Mucopolysaccharides. Brit. J. Dermat. 59: 327, 1947.
168 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
17. SCHMEIDEBERG, 0.: Uber die chemische Zusammensetzung des Knorpels. Arch. Exp.
Path. Pharmak, 28: 355, 1891.
18. LEVENE, P. A.: Hexosamines and Mucoproteins. Landon; Longmans, Green & Co., 1925.
19. MEYER, K., Duaos, R. AND E. M. SatyTil: Action of Lytic principle of pneumococcus
on certain tissue polysaccharides. Proc. Soc. Exper. Biol. & Med. 34: 816, 1936.
20. DURAN-REYNAL5, F.: Exaltation de l'activite du virus vaccinal par les extraits de
certains organes. Compt. rend. Soc. biol. 99: 6, 1928.
21. HALE, C. W.: Histochemical demonstration of acid polysaecharides in animal tissues.
Nature 157: 802, 1946.
22. DURAN-REYNAL5, F.: Tissue permeability and spreading factors in infection; contribu-
tion to host-parasite problem. Bact. Rev. 6: 197, 1942.
